R&D & Innovation
R&D Platform
At present, CuroVax has a R&D team of over 60 members, with approximately 20% holding master’s or doctoral degrees. We have established extensive collaborative relationships with domestic and international research institutes and vaccine R&D enterprises.
We have a highly qualified and experienced R&D team with profound academic and scientific expertise in development of inactivated virus vaccines, recombinant protein vaccines, and mRNA vaccines.
